Skip to content
healthcare.dev
Get a free key

LACOSAMIDE

NDC 51991-351, LACOSAMIDE, tablet, film coated, from Breckenridge Pharmaceutical, Inc..

Product NDC
51991-351
Status
Listed
Labeler
Breckenridge Pharmaceutical, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204921
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51991-351 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE200 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
51991-351-0551991035105500 TABLET, FILM COATED in 1 BOTTLE (51991-351-05)
51991-351-065199103510660 TABLET, FILM COATED in 1 BOTTLE (51991-351-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f7ea3ce6-4ca7-4405-a011-48e7d71360a5

  • NADAC price for package 51991035105

    GET /v1/drugs/nadac/51991035105

  • NADAC price for package 51991035106

    GET /v1/drugs/nadac/51991035106

Use it

Look up 51991-351 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51991-351 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51991-351. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.